Order Article Reprints

Hamed EM, Ibrahim ARN, Meabed MH, Khalaf AM, El Demerdash DM, Elgendy MO, Saeed H, Salem HF, Rabea H. The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. Pharmaceuticals. 2023; 16(6):868. https://doi.org/10.3390/ph16060868

Hamed, Eman Mostafa, Ahmed R. N. Ibrahim, Mohamed Hussein Meabed, Ahmed M. Khalaf, Doaa Mohamed El Demerdash, Marwa O. Elgendy, Haitham Saeed, Heba F. Salem, and Hoda Rabea. 2023. "The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity" Pharmaceuticals 16, no. 6: 868. https://doi.org/10.3390/ph16060868

Hamed, E. M., Ibrahim, A. R. N., Meabed, M. H., Khalaf, A. M., El Demerdash, D. M., Elgendy, M. O., Saeed, H., Salem, H. F., & Rabea, H. (2023). The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. Pharmaceuticals, 16(6), 868. https://doi.org/10.3390/ph16060868